{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:43:13Z","timestamp":1791114193303,"version":"4.1.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"4-6","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["2R01AG032236"],"award-info":[{"award-number":["2R01AG032236"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["5P01AG026572"],"award-info":[{"award-number":["5P01AG026572"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.mam.2011.10.005","type":"journal-article","created":{"date-parts":[[2011,10,25]],"date-time":"2011-10-25T17:00:19Z","timestamp":1319562019000},"page":"247-257","source":"Crossref","is-referenced-by-count":111,"title":["Shift in brain metabolism in late onset Alzheimer\u2019s disease: Implications for biomarkers and therapeutic interventions"],"prefix":"10.1016","volume":"32","author":[{"given":"Jia","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamaica R.","family":"Rettberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren P.","family":"Klosinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Cadenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Diaz","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2011.10.005_b0010","doi-asserted-by":"crossref","first-page":"630865","DOI":"10.4061\/2011\/630865","article-title":"The pathogenesis of Alzheimer\u2019s disease: a reevaluation of the \u201camyloid cascade hypothesis\u201d","author":"Armstrong","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.mam.2011.10.005_b0015","unstructured":"Alzheimer\u2019s Association, A.s., 2011. 2011 Alzheimer\u2019s Disease Facts and Figures 12."},{"issue":"5","key":"10.1016\/j.mam.2011.10.005_b0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.mito.2007.06.001","article-title":"Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer\u2019s disease","volume":"7","author":"Atamna","year":"2007","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.mam.2011.10.005_b0025","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1471-4159.1991.tb11435.x","article-title":"Fatty acid oxidation and ketogenesis by astrocytes in primary culture","volume":"56","author":"Auestad","year":"1991","journal-title":"J. Neurochem."},{"issue":"7","key":"10.1016\/j.mam.2011.10.005_b0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neurobiolaging.2003.09.005","article-title":"Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical \u201cdisconnection\u201d in aging and Alzheimer\u2019s disease","volume":"25","author":"Bartzokis","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.mam.2011.10.005_b0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20624","article-title":"Mitochondria take center stage in aging and neurodegeneration","volume":"58","author":"Beal","year":"2005","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0650","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","article-title":"Neuronal activity regulates the regional vulnerability to amyloid-beta deposition","volume":"14","author":"Bero","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.mam.2011.10.005_b0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1749-6632.2000.tb05576.x","article-title":"The mitochondrial spiral. An adequate cause of dementia in the Alzheimer\u2019s syndrome","volume":"924","author":"Blass","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1\u20133","key":"10.1016\/j.mam.2011.10.005_b0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/MN:24:1-3:087","article-title":"CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer\u2019s disease","volume":"24","author":"Blennow","year":"2001","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0055","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0197-4580(01)00314-1","article-title":"Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer\u2019s disease","volume":"23","author":"Bosetti","year":"2002","journal-title":"Neurobiol. Aging"},{"issue":"13\u201314","key":"10.1016\/j.mam.2011.10.005_b0060","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.addr.2008.06.003","article-title":"Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer\u2019s disease","volume":"60","author":"Brinton","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"13","key":"10.1016\/j.mam.2011.10.005_b0065","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1523\/JNEUROSCI.23-13-05645.2003","article-title":"Presenilin redistribution associated with aberrant cholesterol transport enhances beta-amyloid production in vivo","volume":"23","author":"Burns","year":"2003","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.mam.2011.10.005_b0075","first-page":"1439","article-title":"Functional mitochondria are required for amyloid beta-mediated neurotoxicity","volume":"15","author":"Cardoso","year":"2001","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0197-4580(03)00033-2","article-title":"Cytochrome c oxidase is decreased in Alzheimer\u2019s disease platelets","volume":"25","author":"Cardoso","year":"2004","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.mam.2011.10.005_b0080","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/archneurol.2010.284","article-title":"Longitudinal changes in white matter disease and cognition in the first year of the Alzheimer disease neuroimaging initiative","volume":"67","author":"Carmichael","year":"2010","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-510X(02)00319-2","article-title":"Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer\u2019s disease","volume":"206","author":"Casademont","year":"2003","journal-title":"J. Neurol. Sci."},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0090","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1176\/ajp.2007.164.6.916","article-title":"Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates","volume":"164","author":"Chen","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.mam.2011.10.005_b0095","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","article-title":"Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer\u2019s disease?","volume":"60","author":"Chetelat","year":"2003","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.mam.2011.10.005_b0100","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","article-title":"Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain","volume":"50","author":"Choi","year":"2009","journal-title":"J. Nucl. Med.: Off. Publ. Soc. Nucl. Med."},{"issue":"4","key":"10.1016\/j.mam.2011.10.005_b0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jprot.2010.12.012","article-title":"Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer\u2019s disease","volume":"74","author":"Chou","year":"2011","journal-title":"J. Proteomics"},{"issue":"2","key":"10.1016\/j.mam.2011.10.005_b0005","first-page":"109","article-title":"The Ronald and Nancy Reagan Research Institute of the Alzheimer\u2019s Association and the National Institute on Aging Working Group","volume":"19","author":"Consensus report of the Working Group on: \u201cMolecular, Biochemical Markers of Alzheimer\u2019s Disease\u201d","year":"1998","journal-title":"Neurobiol. Aging"},{"issue":"19","key":"10.1016\/j.mam.2011.10.005_b0110","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","article-title":"Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-d-glucose\/poitron-emission tomography (FDG\/PET)","volume":"98","author":"de Leon","year":"2001","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.mam.2011.10.005_b0115","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archneurol.2010.179","article-title":"Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people","volume":"67","author":"De Meyer","year":"2010","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.mam.2011.10.005_b0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0197-4580(01)00230-5","article-title":"Hippocampal formation glucose metabolism and volume losses in MCI and AD","volume":"22","author":"De Santi","year":"2001","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.mam.2011.10.005_b0655","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/156720511796391872","article-title":"Mitochondria: the common upstream driver of Abeta and tau pathology in Alzheimers disease","volume":"8","author":"Diana","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"43","key":"10.1016\/j.mam.2011.10.005_b0130","doi-asserted-by":"crossref","first-page":"18670","DOI":"10.1073\/pnas.1006586107","article-title":"Early deficits in synaptic mitochondria in an Alzheimer\u2019s disease mouse model","volume":"107","author":"Du","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"Suppl. 2","key":"10.1016\/j.mam.2011.10.005_b0660","doi-asserted-by":"crossref","first-page":"S633","DOI":"10.3233\/JAD-2010-100507","article-title":"Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer\u2019s disease","volume":"20","author":"Dumont","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1212\/WNL.47.1.254","article-title":"Increased risk of dementia in mothers of Alzheimer\u2019s disease cases: evidence for maternal inheritance","volume":"47","author":"Edland","year":"1996","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s001140100237","article-title":"Alzheimer\u2019s disease: molecular concepts and therapeutic targets","volume":"88","author":"Fassbender","year":"2001","journal-title":"Naturwissenschaften"},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0665","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11011-011-9253-y","article-title":"Evaluation of respiratory chain activity in lymphocytes of patients with Alzheimer disease","volume":"26","author":"Feldhaus","year":"2011","journal-title":"Metab. Brain Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.mam.2011.10.005_b0670","doi-asserted-by":"crossref","first-page":"S591","DOI":"10.3233\/JAD-2010-100336","article-title":"A mitocentric view of Alzheimer\u2019s disease suggests multi-faceted treatments","volume":"20","author":"Gibson","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.mam.2011.10.005_b0155","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneur.1988.00520320022009","article-title":"Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer\u2019s disease","volume":"45","author":"Gibson","year":"1988","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.mam.2011.10.005_b0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2011.01.002","article-title":"Anti-abeta therapeutics in Alzheimer\u2019s disease: the need for a paradigm shift","volume":"69","author":"Golde","year":"2011","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0170","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.plefa.2003.05.001","article-title":"Ketone body synthesis in the brain: possible neuroprotective effects","volume":"70","author":"Guzman","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0175","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imaging biomarkers of Alzheimer\u2019s disease","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0180","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol."},{"issue":"3 Suppl.","key":"10.1016\/j.mam.2011.10.005_b0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/JAD-2006-9S317","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis: an update and reappraisal","volume":"9","author":"Hardy","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"5054","key":"10.1016\/j.mam.2011.10.005_b0190","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.mam.2011.10.005_b0195","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neurobiolaging.2007.12.005","article-title":"Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice","volume":"30","author":"Hauptmann","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0200","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.nurt.2008.05.004","article-title":"Ketone bodies as a therapeutic for Alzheimer\u2019s disease","volume":"5","author":"Henderson","year":"2008","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02251132","article-title":"Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases","volume":"3","author":"Hoyer","year":"1991","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0210","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/WNL.50.6.1585","article-title":"Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer\u2019s disease","volume":"50","author":"Ibanez","year":"1998","journal-title":"Neurology"},{"issue":"Pt 6","key":"10.1016\/j.mam.2011.10.005_b0215","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer\u2019s disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain: J. Neurol."},{"issue":"12","key":"10.1016\/j.mam.2011.10.005_b0675","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2174\/156802611795860942","article-title":"gamma-Secretase inhibitors and modulators for the treatment of Alzheimer\u2019s disease: disappointments and hopes","volume":"11","author":"Imbimbo","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0225","first-page":"925","article-title":"Reduction of cerebellar glucose metabolism in advanced Alzheimer\u2019s disease","volume":"38","author":"Ishii","year":"1997","journal-title":"J. Nucl. Med."},{"issue":"Pt 3","key":"10.1016\/j.mam.2011.10.005_b0235","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/awm336","article-title":"11C PiB and structural MRI provide complementary information in imaging of Alzheimer\u2019s disease and amnestic mild cognitive impairment","volume":"131","author":"Jack","year":"2008","journal-title":"Brain: J. Neurol."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.mam.2011.10.005_b0240","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.20799","article-title":"Brain imaging evidence of preclinical Alzheimer\u2019s disease in normal aging","volume":"59","author":"Jagust","year":"2006","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.mam.2011.10.005_b0250","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/jcp.22571","article-title":"Sphingosine induces apoptosis in hippocampal neurons and astrocytes by activating caspase-3\/-9 via a mitochondrial pathway linked to SDK\/14-3-3 protein\/Bax\/cytochrome c","volume":"226","author":"Kanno","year":"2011","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.mam.2011.10.005_b0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuint.2008.10.008","article-title":"Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer\u2019s disease","volume":"54","author":"Karuppagounder","year":"2009","journal-title":"Neurochem. Int."},{"issue":"2","key":"10.1016\/j.mam.2011.10.005_b0260","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/1531-8249(200008)48:2<148::AID-ANA3>3.0.CO;2-7","article-title":"Alzheimer\u2019s disease cybrids replicate beta-amyloid abnormalities through cell death pathways","volume":"48","author":"Khan","year":"2000","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0265","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.mam.2011.10.005_b0270","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/jnen\/62.11.1087","article-title":"Neuropathology of cognitively normal elderly","volume":"62","author":"Knopman","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0275","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jalz.2009.04.1228","article-title":"White matter integrity and cortical metabolic associations in aging and dementia","volume":"6","author":"Kuczynski","year":"2010","journal-title":"Alzheimers Dement."},{"issue":"10","key":"10.1016\/j.mam.2011.10.005_b0280","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archneur.65.10.noc80013","article-title":"Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B","volume":"65","author":"Leinonen","year":"2008","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.mam.2011.10.005_b0285","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1471-4159.2004.02455.x","article-title":"Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice","volume":"89","author":"Li","year":"2004","journal-title":"J. Neurochem."},{"issue":"7113","key":"10.1016\/j.mam.2011.10.005_b0290","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"5669","key":"10.1016\/j.mam.2011.10.005_b0295","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1126\/science.1091230","article-title":"ABAD directly links Abeta to mitochondrial toxicity in Alzheimer\u2019s disease","volume":"304","author":"Lustbader","year":"2004","journal-title":"Science"},{"issue":"Pt 12","key":"10.1016\/j.mam.2011.10.005_b0300","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1242\/jeb.02208","article-title":"Neuron-glia metabolic coupling and plasticity","volume":"209","author":"Magistretti","year":"2006","journal-title":"J. Exp. Biol."},{"issue":"9","key":"10.1016\/j.mam.2011.10.005_b0305","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/hmg\/ddl066","article-title":"Mitochondria are a direct site of A beta accumulation in Alzheimer\u2019s disease neurons: implications for free radical generation and oxidative damage in disease progression","volume":"15","author":"Manczak","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"45","key":"10.1016\/j.mam.2011.10.005_b0310","doi-asserted-by":"crossref","first-page":"37377","DOI":"10.1074\/jbc.M508246200","article-title":"Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-beta peptides","volume":"280","author":"Marambaud","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0315","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","article-title":"[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease","volume":"67","author":"Mintun","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0320","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1212\/WNL.48.3.636","article-title":"Respiratory chain enzyme activities in isolated mitochondria of lymphocytes from patients with Alzheimer\u2019s disease","volume":"48","author":"Molina","year":"1997","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.mam.2011.10.005_b0325","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2006-9202","article-title":"The key role of mitochondria in Alzheimer\u2019s disease","volume":"9","author":"Moreira","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"1\u20132","key":"10.1016\/j.mam.2011.10.005_b0330","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jns.2007.01.017","article-title":"Brain mitochondrial dysfunction as a link between Alzheimer\u2019s disease and diabetes","volume":"257","author":"Moreira","year":"2007","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0335","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbadis.2009.10.007","article-title":"Mitochondria: a therapeutic target in neurodegeneration","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.mam.2011.10.005_b0340","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10545-005-5518-0","article-title":"Cerebral ketone body metabolism","volume":"28","author":"Morris","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"5","key":"10.1016\/j.mam.2011.10.005_b0350","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neurobiolaging.2006.12.008","article-title":"Hippocampal hypometabolism predicts cognitive decline from normal aging","volume":"29","author":"Mosconi","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0355","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1212\/01.wnl.0000333247.51383.43","article-title":"Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease","volume":"72","author":"Mosconi","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.mam.2011.10.005_b0360","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.mam.2011.10.005_b0680","doi-asserted-by":"crossref","DOI":"10.3233\/JAD-2011-110866","article-title":"Reduced mitochondria cytochrome oxidase activity in adult children of mothers with Alzheimer\u2019s disease","author":"Mosconi","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.mam.2011.10.005_b0685","article-title":"Maternal age affects brain metabolism in adult children of mothers affected by Alzheimer\u2019s disease","author":"Mosconi","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mam.2011.10.005_b0370","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.brainres.2010.05.084","article-title":"Regional cerebral glucose uptake in the 3xTG model of Alzheimer\u2019s disease highlights common regional vulnerability across AD mouse models","volume":"1347","author":"Nicholson","year":"2010","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.mam.2011.10.005_b0385","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/jnen\/60.8.759","article-title":"Oxidative damage is the earliest event in Alzheimer disease","volume":"60","author":"Nunomura","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0375","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nbd.2004.06.003","article-title":"Neuronal RNA oxidation is a prominent feature of familial Alzheimer\u2019s disease","volume":"17","author":"Nunomura","year":"2004","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0380","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-009-0508-1","article-title":"RNA oxidation in Alzheimer disease and related neurodegenerative disorders","volume":"118","author":"Nunomura","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0390","doi-asserted-by":"crossref","first-page":"e21745","DOI":"10.1371\/journal.pone.0021745","article-title":"Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer\u2019s disease","volume":"6","author":"O\u2019Dwyer","year":"2011","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0395","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3164\/jcbn.11-005FR","article-title":"Lipoic acid: energy metabolism and redox regulation of transcription and cell signaling","volume":"48","author":"Packer","year":"2011","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"5","key":"10.1016\/j.mam.2011.10.005_b0400","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1046\/j.1471-4159.1999.0721948.x","article-title":"Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia","volume":"72","author":"Park","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mam.2011.10.005_b0405","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.1991.tb00191.x","article-title":"Cytochrome oxidase deficiency in Alzheimer\u2019s disease","volume":"640","author":"Parker","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"8","key":"10.1016\/j.mam.2011.10.005_b0410","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1212\/WNL.40.8.1302","article-title":"Cytochrome oxidase deficiency in Alzheimer\u2019s disease","volume":"40","author":"Parker","year":"1990","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0415","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1212\/WNL.44.6.1086","article-title":"Reduced platelet cytochrome c oxidase activity in Alzheimer\u2019s disease","volume":"44","author":"Parker","year":"1994","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0420","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(80)90220-7","article-title":"Coenzyme A-acetylating enzymes in Alzheimer\u2019s disease: possible cholinergic \u2018compartment\u2019 of pyruvate dehydrogenase","volume":"18","author":"Perry","year":"1980","journal-title":"Neurosci. Lett."},{"issue":"1\u20132","key":"10.1016\/j.mam.2011.10.005_b0425","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12031-002-0026-2","article-title":"Statin therapy for Alzheimer\u2019s disease: will it work?","volume":"19","author":"Petanceska","year":"2002","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0430","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.biocel.2008.12.015","article-title":"Reassessing the amyloid cascade hypothesis of Alzheimer\u2019s disease","volume":"41","author":"Pimplikar","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"12","key":"10.1016\/j.mam.2011.10.005_b0435","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1523\/JNEUROSCI.21-12-04183.2001","article-title":"Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis","volume":"21","author":"Pratico","year":"2001","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0440","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer\u2019s disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.mam.2011.10.005_b0445","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/alzrt28","article-title":"Can novel therapeutics halt the amyloid cascade?","volume":"2","author":"Prins","year":"2010","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.mam.2011.10.005_b0450","doi-asserted-by":"crossref","first-page":"104545","DOI":"10.4061\/2011\/104545","article-title":"Mitochondria, amyloid beta, and Alzheimer\u2019s disease","author":"Readnower","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0455","first-page":"31372","article-title":"Mitochondrial oxidative damage in aging and Alzheimer\u2019s disease: implications for mitochondrially targeted antioxidant therapeutics","author":"Reddy","year":"2006","journal-title":"J. Biomed. Biotechnol."},{"issue":"2","key":"10.1016\/j.mam.2011.10.005_b0460","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer\u2019s disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0465","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"47","key":"10.1016\/j.mam.2011.10.005_b0470","doi-asserted-by":"crossref","first-page":"20057","DOI":"10.1073\/pnas.0905529106","article-title":"Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer\u2019s disease mice","volume":"106","author":"Rhein","year":"2009","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.mam.2011.10.005_b0475","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156720509788929273","article-title":"Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort","volume":"6","author":"Risacher","year":"2009","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.mam.2011.10.005_b0480","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-009-0583-3","article-title":"Deficient high-affinity binding of Pittsburgh Compound B in a case of Alzheimer\u2019s disease","volume":"119","author":"Rosen","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.mam.2011.10.005_b0690","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/WNL.0b013e31821cccad","article-title":"Distinct clinical and metabolic deficits in PCA and AD are not related to amyloid distribution","volume":"76","author":"Rosenbloom","year":"2011","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mam.2011.10.005_b0490","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archneurol.2011.69","article-title":"Lack of evidence for the efficacy of memantine in mild Alzheimer disease","volume":"68","author":"Schneider","year":"2011","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0495","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/archneurol.2010.343","article-title":"Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer\u2019s disease neuroimaging initiative","volume":"68","author":"Schneider","year":"2011","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0695","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-2011-110423","article-title":"Amyloid-beta-induced mitochondrial dysfunction impairs the autophagic lysosomal pathway in a tubulin dependent pathway","volume":"26","author":"Silva","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"11","key":"10.1016\/j.mam.2011.10.005_b0505","first-page":"667","article-title":"Perspectives on the amyloid cascade hypothesis of Alzheimer\u2019s disease","volume":"50","author":"Simon","year":"2010","journal-title":"Rev. Neurol."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0510","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1471-4892(01)00126-6","article-title":"Alzheimer\u2019s disease and the amyloid cascade hypothesis: ten years on","volume":"2","author":"Sommer","year":"2002","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0515","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410130116","article-title":"Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain","volume":"13","author":"Sorbi","year":"1983","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0520","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"9","key":"10.1016\/j.mam.2011.10.005_b0700","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.neurobiolaging.2008.08.018","article-title":"Whole brain atrophy rate predicts progression from MCI to Alzheimer\u2019s disease","volume":"31","author":"Spulber","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"36","key":"10.1016\/j.mam.2011.10.005_b0530","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1523\/JNEUROSCI.1899-04.2004","article-title":"Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species","volume":"24","author":"Starkov","year":"2004","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.mam.2011.10.005_b0535","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1002\/jnr.21167","article-title":"Mitochondria in cybrids containing mtDNA from persons with mitochondriopathies","volume":"85","author":"Swerdlow","year":"2007","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0545","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mehy.2003.12.045","article-title":"A \u201cmitochondrial cascade hypothesis\u201d for sporadic Alzheimer\u2019s disease","volume":"63","author":"Swerdlow","year":"2004","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.mam.2011.10.005_b0550","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.expneurol.2009.01.011","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis: an update","volume":"218","author":"Swerdlow","year":"2009","journal-title":"Exp. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/j.mam.2011.10.005_b0705","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.3233\/JAD-2010-100339","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis","volume":"20","author":"Swerdlow","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0555","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1096\/fj.04-2582fje","article-title":"ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction","volume":"19","author":"Takuma","year":"2005","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0560","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jalz.2010.03.008","article-title":"Update on the biomarker core of the Alzheimer\u2019s disease neuroimaging initiative subjects","volume":"6","author":"Trojanowski","year":"2010","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.mam.2011.10.005_b0565","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.neuroscience.2006.10.056","article-title":"Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases","volume":"145","author":"Trushina","year":"2007","journal-title":"Neuroscience"},{"issue":"41","key":"10.1016\/j.mam.2011.10.005_b0570","doi-asserted-by":"crossref","first-page":"17757","DOI":"10.1073\/pnas.1010459107","article-title":"Regional aerobic glycolysis in the human brain","volume":"107","author":"Vaishnavi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0575","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.mito.2006.10.004","article-title":"Impaired platelet mitochondrial activity in Alzheimer\u2019s disease and mild cognitive impairment","volume":"6","author":"Valla","year":"2006","journal-title":"Mitochondrion"},{"issue":"8","key":"10.1016\/j.mam.2011.10.005_b0580","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbalip.2010.03.007","article-title":"Membrane rafts in Alzheimer\u2019s disease beta-amyloid production","volume":"1801","author":"Vetrivel","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.mam.2011.10.005_b0585","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/brain\/awq203","article-title":"Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer\u2019s disease","volume":"133","author":"Villain","year":"2010","journal-title":"Brain"},{"issue":"Suppl. 2","key":"10.1016\/j.mam.2011.10.005_b0710","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1186\/1471-2202-9-S2-S6","article-title":"Therapeutic potential of resveratrol in Alzheimer\u2019s disease","volume":"9","author":"Vingtdeux","year":"2008","journal-title":"BMC Neurosci."},{"issue":"41","key":"10.1016\/j.mam.2011.10.005_b0595","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1073\/pnas.1010461107","article-title":"Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition","volume":"107","author":"Vlassenko","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mam.2011.10.005_b0600","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","article-title":"A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine","volume":"39","author":"Wallace","year":"2005","journal-title":"Annu. Rev. Genet."},{"issue":"4","key":"10.1016\/j.mam.2011.10.005_b0605","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1471-4159.2005.03053.x","article-title":"Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer\u2019s disease","volume":"93","author":"Wang","year":"2005","journal-title":"J. Neurochem."},{"issue":"Pt 7","key":"10.1016\/j.mam.2011.10.005_b0610","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/brain\/awm112","article-title":"3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer\u2019s disease","volume":"130","author":"Whitwell","year":"2007","journal-title":"Brain"},{"issue":"7355","key":"10.1016\/j.mam.2011.10.005_b0615","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1038\/475S5a","article-title":"Biomarkers: warning signs","volume":"475","author":"Williams","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mam.2011.10.005_b0620","first-page":"223","article-title":"Alzheimer\u2019s disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners","volume":"15","author":"Wollen","year":"2010","journal-title":"Altern. Med. Rev."},{"issue":"6","key":"10.1016\/j.mam.2011.10.005_b0625","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2967\/jnumed.109.069088","article-title":"In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)","volume":"51","author":"Wong","year":"2010","journal-title":"J. Nucl. Med.: Off. Publ. Soc. Nucl. Med."},{"issue":"34","key":"10.1016\/j.mam.2011.10.005_b0635","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0903563106","article-title":"Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease","volume":"106","author":"Yao","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.mam.2011.10.005_b0630","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.bbagen.2010.06.002","article-title":"Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence","volume":"1800","author":"Yao","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.mam.2011.10.005_b0715","doi-asserted-by":"crossref","first-page":"e21788","DOI":"10.1371\/journal.pone.0021788","article-title":"2-Deoxy-d-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer\u2019s disease","volume":"6","author":"Yao","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl. 2","key":"10.1016\/j.mam.2011.10.005_b0720","doi-asserted-by":"crossref","first-page":"S381","DOI":"10.3233\/JAD-2010-100360","article-title":"The mitochondrial secret(ase) of Alzheimer\u2019s disease","volume":"20","author":"Young","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.mam.2011.10.005_b0645","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1212\/01.wnl.0000250326.77323.01","article-title":"Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease","volume":"68","author":"Zhang","year":"2007","journal-title":"Neurology"}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299711000495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299711000495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T08:05:41Z","timestamp":1741853141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299711000495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":129,"journal-issue":{"issue":"4-6","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0098299711000495"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2011.10.005","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}